Evaluation of nitazoxanide in combination with pegylated interferon and ribavirin in treatment of patients with chronic HCV genotype 4 / Mahmoud Mohammad Magdy Taha ; Supervised Gamal Eldeen Esmat Gameel , Maissa Elsaid Elraziky , Badawy Elkholy

By:

Mahmoud Mohammad Magdy Taha

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Mahmoud Mohammad Magdy Taha , 2012Description: 76P. : charts , facsimiles ; 25cmOther title:

تقييم عقار النيتازوكسانيد فى علاج المرضى المصابين بالتهاب الكبد الفيروسى ج المزمن الطور الجينى الرابع مع الإنترفيرون والريبافيرين [Added title page title]

Subject(s):

Online resources:

Click here to access online

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine Summary: Sustained virologic response (SVR ) rates of 50 % - 60 % have been achieved in patients with chronic hepatitis C (CHC) genotype 4 treated with peginterferon (PEG-IFN) plus ribavirin (RBV) . The safety and efficacy of nitazoxanide (NTZ) plus peginterferon alfa-2a , with ribavirin , were evaluated in a case controlled study at 2 centers in Egypt . This study aims at assessing the safety and efficacy of NTZ in treating Egyptian patients with CHC in combination with PEG-IFN and RBV

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.33.Ph.D.2012.Ma.E (Browse shelf(Opens below))		Not for loan	01010110060146000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.33.Ph.D.2012.Ma.E (Browse shelf(Opens below))	60146.CD	Not for loan	01020110060146000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.11.33.Ph.D.2012.Eh.A Alrerations of gluathione S - transferase and matrix metalloproteinase - 9 expression in gastroesopageal reflux disease and esophageal carcinoma /	Cai01.11.33.Ph.D.2012.He.M Molecular markers for early detection of hepatocellular carcinoma /	Cai01.11.33.Ph.D.2012.He.M Molecular markers for early detection of hepatocellular carcinoma /	Cai01.11.33.Ph.D.2012.Ma.E Evaluation of nitazoxanide in combination with pegylated interferon and ribavirin in treatment of patients with chronic HCV genotype 4 /	Cai01.11.33.Ph.D.2012.Ma.E Evaluation of nitazoxanide in combination with pegylated interferon and ribavirin in treatment of patients with chronic HCV genotype 4 /	Cai01.11.33.Ph.D.2012.Ma.N Newer tumor markers in detection of colorectal carcinoma /	Cai01.11.33.Ph.D.2012.Ma.N Newer tumor markers in detection of colorectal carcinoma /	Next

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine

Sustained virologic response (SVR ) rates of 50 % - 60 % have been achieved in patients with chronic hepatitis C (CHC) genotype 4 treated with peginterferon (PEG-IFN) plus ribavirin (RBV) . The safety and efficacy of nitazoxanide (NTZ) plus peginterferon alfa-2a , with ribavirin , were evaluated in a case controlled study at 2 centers in Egypt . This study aims at assessing the safety and efficacy of NTZ in treating Egyptian patients with CHC in combination with PEG-IFN and RBV

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer